Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × pembrolizumab × Tumor-Agnostic × Clear all

Status

Sponsor Class

Study Type

Interventional 82 Observational 1

Sponsor

Cancer Type

Thoracic 15 Dermatologic 10 Head & Neck 6 Genitourinary 5 Gastrointestinal 5 Breast 2 Tumor-Agnostic 1 Other 1 CNS 1

Conditions

Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 36 Blood Specimen Collection 17 Interviews as Topic 12 Data Collection 11 Magnetic Resonance Spectroscopy 6 Radiotherapy 5 Hematologic Tests 5 Specimen Handling 4 Palliative Care 4 Mental Status and Dementia Tests 4 Restraint, Physical 3 Registries 3 Quality of Life 3 Phlebotomy 3 Observation 3 Neoadjuvant Therapy 3 Lapatinib 3 Immunotherapy 3 Focus Groups 3 Drug Therapy 3 veliparib 2 talazoparib 2 rucaparib 2 pamiparib 2 olaparib 2 niraparib 2 Wearable Electronic Devices 2 Therapeutics 2 Radiosurgery 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03453892 2023-02-16

ST-ICI

University of Erlangen-Nürnberg Medical School

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡